BACKGROUND: While inadequate treatment intensification may contribute to sub-optimal CVD risk factor control in older patients with diabetes, the relationship between patient age and treatment intensification is largely unexplored. OBJECTIVE: To examine differences in treatment intensification and control for blood pressure (BP), lipids and A1c in older vs. younger adults with diabetes. METHODS: A total of 161,697 Kaiser Permanente Northern California adult diabetes patients were stratified by age (<50, 50-64, 65-74 and 75-85) and assessed for control of A1c (<8%), LDL-c (<100 mg/dl) and SBP (<140 mmHg). Probit models assessed the marginal effects of patient age on treatment intensification and control for all three CVD risk factors. RESULTS: Patients aged 50-64 and 65-74 were significantly more likely to receive treatment intensification for elevated SBP than patients under 50 (74% and 76% vs. 71%) and significantly less likely to receive treatment intensification for elevated A1c (73% and 72% vs. 76%), with no differences noted for LDL-c treatment. Older patients had significantly worse SBP control, but better control of A1c and LDL-c. CONCLUSIONS: Both treatment intensification rates and control of BP, A1c and LDL cholesterol control varied somewhat by age, suggesting room for further improvement in treatment intensification and control.
BACKGROUND: While inadequate treatment intensification may contribute to sub-optimal CVD risk factor control in older patients with diabetes, the relationship between patient age and treatment intensification is largely unexplored. OBJECTIVE: To examine differences in treatment intensification and control for blood pressure (BP), lipids and A1c in older vs. younger adults with diabetes. METHODS: A total of 161,697 Kaiser Permanente Northern California adult diabetespatients were stratified by age (<50, 50-64, 65-74 and 75-85) and assessed for control of A1c (<8%), LDL-c (<100 mg/dl) and SBP (<140 mmHg). Probit models assessed the marginal effects of patient age on treatment intensification and control for all three CVD risk factors. RESULTS:Patients aged 50-64 and 65-74 were significantly more likely to receive treatment intensification for elevated SBP than patients under 50 (74% and 76% vs. 71%) and significantly less likely to receive treatment intensification for elevated A1c (73% and 72% vs. 76%), with no differences noted for LDL-c treatment. Older patients had significantly worse SBP control, but better control of A1c and LDL-c. CONCLUSIONS: Both treatment intensification rates and control of BP, A1c and LDL cholesterol control varied somewhat by age, suggesting room for further improvement in treatment intensification and control.
Authors: Michael M Engelgau; Linda S Geiss; Jinan B Saaddine; James P Boyle; Stephanie M Benjamin; Edward W Gregg; Edward F Tierney; Nilka Rios-Burrows; Ali H Mokdad; Earl S Ford; Giuseppina Imperatore; K M Venkat Narayan Journal: Ann Intern Med Date: 2004-06-01 Impact factor: 25.391
Authors: Giuseppina Imperatore; Betsy L Cadwell; Linda Geiss; Jinan B Saadinne; Desmond E Williams; Earl S Ford; Theodore J Thompson; K M Venkat Narayan; Edward W Gregg Journal: Am J Epidemiol Date: 2004-09-15 Impact factor: 4.897
Authors: Margaret D Carroll; David A Lacher; Paul D Sorlie; James I Cleeman; David J Gordon; Michael Wolz; Scott M Grundy; Clifford L Johnson Journal: JAMA Date: 2005-10-12 Impact factor: 56.272
Authors: J D Curb; S L Pressel; J A Cutler; P J Savage; W B Applegate; H Black; G Camel; B R Davis; P H Frost; N Gonzalez; G Guthrie; A Oberman; G H Rutan; J Stamler Journal: JAMA Date: 1996-12-18 Impact factor: 56.272
Authors: Nicolas Rodondi; Tiffany Peng; Andrew J Karter; Douglas C Bauer; Eric Vittinghoff; Simon Tang; Daniel Pettitt; Eve A Kerr; Joe V Selby Journal: Ann Intern Med Date: 2006-04-04 Impact factor: 25.391
Authors: Julie A Schmittdiel; Connie S Uratsu; Andrew J Karter; Michele Heisler; Usha Subramanian; Carol M Mangione; Joe V Selby Journal: J Gen Intern Med Date: 2008-03-04 Impact factor: 5.128
Authors: Patrick J O'Connor; William A Rush; Gestur Davidson; Thomas A Louis; Leif I Solberg; Lauren Crain; Paul E Johnson; Robin R Whitebird Journal: Prev Chronic Dis Date: 2007-12-15 Impact factor: 2.830
Authors: Jing Wang; Linda S Geiss; Yiling J Cheng; Giuseppina Imperatore; Sharon H Saydah; Cherie James; Edward W Gregg Journal: Diabetes Care Date: 2011-05-20 Impact factor: 19.112
Authors: Rebecca S Etz; Rosalind E Keith; Anna M Maternick; Karen L Stein; Roy T Sabo; Melissa S Hayes; Purvi Sevak; John Holland; Jesse C Crosson Journal: Implement Sci Date: 2015-04-09 Impact factor: 7.327